| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w26751 |
| 来源ID | Working Paper 26751 |
| Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D | |
| Colleen Carey; Ethan M.J. Lieber; Sarah Miller | |
| 发表日期 | 2020-02-17 |
| 出版年 | 2020 |
| 语种 | 英语 |
| 摘要 | In a pervasive but controversial practice, drug firms frequently make monetary or in-kind payments to physicians in the course of promoting prescription drugs. We use a federal database on the universe of such payments between 2013 and 2015 linked to prescribing behavior in Medicare Part D. We account for the targeting of payments with fixed effects for each physician-drug combination. In an event study, we show that physicians increase prescribing of drugs for which they receive payments in the months just after payment receipt, with no evidence of differential trends between paid and unpaid physicians prior to the payment. Next, we examine five case studies of major drugs going off patent. Physicians receiving payments from the firms experiencing the patent expiry transition their patients just as quickly to generics as physicians who do not receive such payments. In addition, using hand-collected efficacy data on three major therapeutic classes, we show that drug quality is largely unaffected by the receipt of payments. |
| 主题 | Microeconomics ; Economics of Information ; Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance |
| URL | https://www.nber.org/papers/w26751 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/584425 |
| 推荐引用方式 GB/T 7714 | Colleen Carey,Ethan M.J. Lieber,Sarah Miller. Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D. 2020. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w26751.pdf（483KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
